Citations (54)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (54)
Ling Zhang, Ziruoyu Wang, Kailu Liu, Yihang Liu, Shuai Wang, Wei Jiang, Fanghui Lu & Yongjun Dang. (2024) Targets of tumor microenvironment for potential drug development. MedComm – Oncology 3:1.
Crossref
Crossref
Xiaoting Chen, Qian Cai, Kaiyi Wong, Ximing Shen & Zhong Guan. (2024) Bioinformatic analysis reveals prognostic value and immunotherapy potential of Siglec-15 in laryngeal squamous cell carcinoma. Heliyon 10:3, pages e25266.
Crossref
Crossref
Yixian Wang, Zhan Xu, Kuan-Lin Wu, Liqun Yu, Chenhang Wang, Haoxue Ding, Yang Gao, Han Sun, Yi-Hsuan Wu, Meng Xia, Yuda Chen & Han Xiao. (2024) Siglec-15/sialic acid axis as a central glyco-immune checkpoint in breast cancer bone metastasis. Proceedings of the National Academy of Sciences 121:5.
Crossref
Crossref
Haokang Feng, Jiale Feng, Xu Han, Ying Ying, Wenhui Lou, Liang Liu & Lei Zhang. (2024) The Potential of Siglecs and Sialic Acids as Biomarkers and Therapeutic Targets in Tumor Immunotherapy. Cancers 16:2, pages 289.
Crossref
Crossref
Amobichukwu K. Ogbodo, Denis Mustafov, Mohit Arora, George I. Lambrou, Maria Braoudaki & Shoib S. Siddiqui. (2024) Analysis of SIGLEC12 expression, immunomodulation and prognostic value in renal cancer using multiomic databases. Heliyon 10:2, pages e24286.
Crossref
Crossref
Ziqi Huang, Yan Guo, Baihui Li, Meng Shen, Yeran Yi, Li Li, Xiaohe Zhao & Lili Yang. (2023) Siglec-15 on macrophages suppress the immune microenvironment in patients with PD-L1 negative non-metastasis lung adenocarcinoma. Cancer Gene Therapy.
Crossref
Crossref
Zheng Huo, LiShuo Guo, Wei Shao, Qian Ding, Yue Guo & Qian Xu. (2023) CRNDE, an enhancer RNA of prognostic value in glioma, correlates with immune infiltration: A pan-cancer analysis. European Journal of Inflammation 21, pages 1721727X2211380.
Crossref
Crossref
Kelly Boelaars & Yvette van Kooyk. (2023) Targeting myeloid cells for cancer immunotherapy: Siglec-7/9/10/15 and their ligands. Trends in Cancer.
Crossref
Crossref
Xiaodi Liu, Qi Zhang, Yixia Liang, Shiyu Xiong, Yan Cai, Jincheng Cao, Yanni Xu, Xiaolin Xu, Ye Wu, Qiang Lu, Xiaoding Xu & Baoming Luo. (2023) Nanoparticles (NPs)-mediated Siglec15 silencing and macrophage repolarization for enhanced cancer immunotherapy. Acta Pharmaceutica Sinica B 13:12, pages 5048-5059.
Crossref
Crossref
Mohammed Saqif Ahmad, Maria Braoudaki, Hershna Patel, Irshad Ahmad, Shagufta & Shoib Sarwar Siddiqui. (2023) Novel Siglec-15-Sia axis inhibitor leads to colorectal cancer cell death by targeting miR-6715b-3p and oncogenes. Frontiers in Immunology 14.
Crossref
Crossref
Yixian Guo, Shouyu Ke, Feng Xie, Jieqiong Chen, Xu Liu, Zeyu Wang, Danhua Xu, Yanying Shen, Gang Zhao, Wenyi Zhao & Hong Lu. (2023) SIGLEC10+ macrophages drive gastric cancer progression by suppressing CD8+ T cell function. Cancer Immunology, Immunotherapy 72:10, pages 3229-3242.
Crossref
Crossref
Baihui Li, Yan Guo, Yeran Yi, Ziqi Huang, Yulin Ren, Hao Wang & Lili Yang. (2023) Non-spatial and spatial heterogeneity revealed a suppressive immune feature of Siglec-15 in lung adenocarcinomas. Journal of Translational Medicine 21:1.
Crossref
Crossref
Bin Liu, Xiaoli Fu, Yuhui Du, Zichen Feng, Ruiqin Chen, Xiaoxue Liu, Fangfang Yu, Guoyu Zhou & Yue Ba. (2023)
Pan-cancer analysis of
G6PD
carcinogenesis in human tumors
. Carcinogenesis 44:6, pages 525-534.
Crossref
Crossref
Minna Mutka, Kristiina Joensuu, Marja Heiskala, Mine Eray & Päivi Heikkilä. (2023) Core needle biopsies alter the amounts of CCR5, Siglec-15, and PD-L1 positivities in breast carcinoma. Virchows Archiv 483:2, pages 215-224.
Crossref
Crossref
Tiefeng Jin, Wei Wang, Luqi Ge, Xiang Li & Minghua Ge. (2023) The expression of two immunosuppressive SIGLEC family molecules in papillary thyroid cancer and their effect on prognosis. Endocrine 82:3, pages 590-601.
Crossref
Crossref
Maria Pia Lenza, Leire Egia-Mendikute, Asier Antoñana-Vildosola, Cátia O. Soares, Helena Coelho, Francisco Corzana, Alexandre Bosch, Prodhi Manisha, Jon Imanol Quintana, Iker Oyenarte, Luca Unione, María Jesús Moure, Mikel Azkargorta, Unai Atxabal, Klaudia Sobczak, Felix Elortza, James D. Sutherland, Rosa Barrio, Filipa Marcelo, Jesús Jiménez-Barbero, Asis Palazon & June Ereño-Orbea. (2023) Structural insights into Siglec-15 reveal glycosylation dependency for its interaction with T cells through integrin CD11b. Nature Communications 14:1.
Crossref
Crossref
Huandi Ding, Bing Yao, Lei Ci, Jing Feng, Pingkai Ouyang, Guoguang Chen, Xiwu Hui & Demin Zhou. (2023) Enhancing the Anti-tumor Potency of a Novel Siglec-15 Antibody by Engineering its Fc-mediated Effector Functions. Journal of Immunotherapy 46:5, pages 161-169.
Crossref
Crossref
Xiyun Hu, Weidong Liu, Meiqi He, Qimiao Qiu, Bingjie Zhou, Ruining Liu, Fengxu Wu & Zunnan Huang. (2023) Comparison of the molecular mechanisms of Fuzi Lizhong Pill and Huangqin decoction in the treatment of the cold and heat syndromes of ulcerative colitis based on network pharmacology. Computers in Biology and Medicine 159, pages 106870.
Crossref
Crossref
Jinchao Wang, Linzong Xu, Qian Ding, Xiaoru Li, Kai Wang, Shangchen Xu & Bin Liu. (2023) Siglec15 is a prognostic indicator and a potential tumor-related macrophage regulator that is involved in the suppressive immunomicroenvironment in gliomas. Frontiers in Immunology 14.
Crossref
Crossref
Quan Chen, Bingkun Chen, Chunhua Wang, Li Hu, Qiongwen Wu, Yanyang Zhu & Qiuyu Zhang. (2023) Dynamic change in Siglec-15 expression in peritumoral macrophages confers an immunosuppressive microenvironment and poor outcome in glioma. Frontiers in Immunology 14.
Crossref
Crossref
Yan Li, Feiyang Na & Jianying Pei. (2023) Construction and characterization of a cuproptosis- and immune checkpoint-based LncRNAs signature for breast cancer risk stratification. Breast Cancer 30:3, pages 393-411.
Crossref
Crossref
Ruohuang Wang, Jisheng Zhang, Xin Cui, Shun Wang, Ting Chen, Yanfang Niu, Xiaoyun Du, Jingwen Kong, Lin Wang & Yan Jiang. (2023) Multimolecular characteristics and role of BRCA1 interacting protein C-terminal helicase 1 (BRIP1) in human tumors: a pan-cancer analysis. World Journal of Surgical Oncology 21:1.
Crossref
Crossref
Zhao Lu, Pu Cheng, Fei Huang, Jiyun Li, Bingzhi Wang, Shuangmei Zou, Zhaoxu Zheng & Chunwei Peng. (2022) Significance of Siglec‐15 expression in colorectal cancer: association with advanced disease stage and fewer tumor‐infiltrating lymphocytes. The Journal of Pathology: Clinical Research 9:2, pages 121-128.
Crossref
Crossref
Kui-Ying Jiang, Li-Li Qi, Xin-Bo Liu, Yong Wang & Ling Wang. (2023) Prognostic value of Siglec-15 expression in patients with solid tumors: A meta-analysis. Frontiers in Oncology 12.
Crossref
Crossref
Sha Zhou, Yuting Wang, Rui Zhang, Weian Zeng, Shiliang Liu, Songran Liu, Mengzhong Liu, Hong Yang & Mian Xi. (2023) Association of Sialic Acid–Binding Immunoglobulin-Like Lectin 15 With Phenotypes in Esophageal Squamous Cell Carcinoma in the Setting of Neoadjuvant Chemoradiotherapy. JAMA Network Open 6:1, pages e2250965.
Crossref
Crossref
Kaiqin Sheng, Yuecheng Wu, Hanbin Lin, Menghan Fang, Chaorong Xue, Xu Lin & Xinjian Lin. (2023) Transcriptional Regulation of Siglec-15 by ETS-1 and ETS-2 in Hepatocellular Carcinoma Cells. International Journal of Molecular Sciences 24:1, pages 792.
Crossref
Crossref
Rui Huang, Jinxiu Zheng, Ying Shao, Lei Zhu & Tao Yang. (2023) Siglec-15 as multifunctional molecule involved in osteoclast differentiation, cancer immunity and microbial infection. Progress in Biophysics and Molecular Biology 177, pages 34-41.
Crossref
Crossref
Chang Shi, Lizhi Zhang, Dan Chen, Hong Wei, Wenjing Qi, Pengxin Zhang, Huiqi Guo & Lei Sun. (2022) Prognostic value of TMEM59L and its genomic and immunological characteristics in cancer. Frontiers in Immunology 13.
Crossref
Crossref
Chunmou Li, Luping Wen, Junchao Dong, Lindi Li, Junbin Huang, Jing Yang, Tianqi Liang, Tianwen Li, Zhigang Xia & Chun Chen. (2022) Alterations in cellular metabolisms after TKI therapy for Philadelphia chromosome-positive leukemia in children: A review. Frontiers in Oncology 12.
Crossref
Crossref
Kui-Ying Jiang, Li-Li Qi, Fu-Biao Kang & Ling Wang. (2022) The intriguing roles of Siglec family members in the tumor microenvironment. Biomarker Research 10:1.
Crossref
Crossref
Saba Shafi, Thazin Nwe Aung, Vasiliki Xirou, Niki Gavrielatou, Ioannis A. Vathiotis, Aileen Fernandez, Myrto Moutafi, Vesal Yaghoobi, Roy S. Herbst, Linda N. Liu, Sol Langermann & David L. Rimm. (2022) Quantitative assessment of Siglec-15 expression in lung, breast, head, and neck squamous cell carcinoma and bladder cancer. Laboratory Investigation 102:10, pages 1143-1149.
Crossref
Crossref
Chenjiao Yao, Ruoyao Xu, Qianyuan Li, Sheng Xiao, Min Hu, Linyong Xu & Quan Zhuang. (2022) Identification and validation of an immunological microenvironment signature and prediction model for epstein-barr virus positive lymphoma: Implications for immunotherapy. Frontiers in Oncology 12.
Crossref
Crossref
Xiaofeng Hou, Chao Chen, Xiabin Lan & Xiaodong He. (2022) Unveiling the molecular features, relevant immune and clinical characteristics of SIGLEC15 in thyroid cancer. Frontiers in Immunology 13.
Crossref
Crossref
Jiaguo Wu, Jingyi Peng, Yangyihua Zhou, Ran Zhang, Zhihong Wang, Naijing Hu, Dingmu Zhang, Guiqi Quan, Yuanyu Wu, Jiannan Feng, Beifen Shen, Jian Zhao, Yan Zhang, Kaiming Yang & Longlong Luo. (2022) Screening and Identification of a Novel Anti–Siglec-15 Human Antibody 3F1 and Relevant Antitumor Activity. Molecular Pharmacology 102:3, pages 161-171.
Crossref
Crossref
Zi-Yue Zhao, Zhuo-Yuan Chen, Bin Yu, Bo Xiao, Li-Yan Liu, Yu Xia, Ao-Yu Li, Ping-Xiao Wang, Cheng Xiang, Chao Liu, Hui-Qin Yang, Hui Li & Tao Xiao. (2022) Characterization of the immune cell infiltration landscape in myxofibrosarcoma to aid immunotherapy. Frontiers in Immunology 13.
Crossref
Crossref
Saba Shafi, Thazin Nwe Aung, Charles Robbins, Jon Zugazagoitia, Ioannis Vathiotis, Niki Gavrielatou, Vesal Yaghoobi, Aileen Fernandez, Shuqiong Niu, Linda N. Liu, Zachary T. Cusumano, Nalin Leelatian, Kimberley Cole, He Wang, Robert Homer, Roy S. Herbst, Sol Langermann & David L. Rimm. (2022) Development of an immunohistochemical assay for Siglec-15. Laboratory Investigation 102:7, pages 771-778.
Crossref
Crossref
Xuejun Xiao, Yan Peng, Zheyue Wang, Louqian Zhang, Tingting Yang, Yangyang Sun, Yufeng Chen, Wenqing Zhang, Xinxia Chang, Wen Huang, Shuning Tian, Zhenqing Feng, Nabi Xinhua, Qi Tang & Yuan Mao. (2022) A novel immune checkpoint siglec-15 antibody inhibits LUAD by modulating mφ polarization in TME. Pharmacological Research 181, pages 106269.
Crossref
Crossref
Ju Zhao, Hanshan Yang, Hui Hu, Chao Liu, Min Wei, Yumei Zhao, Yudan Chen, Yongxia Cui, Ping Chen, Kang Xiong, Yun Lu, Hongru Yang & Linglin Yang. (2022) Prognostic value of PD-L1 and Siglec-15 expression in patients with nasopharyngeal carcinoma. Scientific Reports 12:1.
Crossref
Crossref
Xi Cao, Yidong Zhou, Feng Mao, Yan Lin, Xingtong Zhou & Qiang Sun. (2022) Identification and characterization of three Siglec15-related immune and prognostic subtypes of breast-invasive cancer. International Immunopharmacology 106, pages 108561.
Crossref
Crossref
Xianlong Chen, Shengwei Mo, Yue Zhang, Heng Ma, Zhaohui Lu, Shuangni Yu & Jie Chen. (2022) Analysis of a novel immune checkpoint, Siglec‐15, in pancreatic ductal adenocarcinoma. The Journal of Pathology: Clinical Research 8:3, pages 268-278.
Crossref
Crossref
Matthew D. Vesely, Tianxiang ZhangLieping Chen. (2022) Resistance Mechanisms to Anti-PD Cancer Immunotherapy. Annual Review of Immunology 40:1, pages 45-74.
Crossref
Crossref
Ying Kong, Hao Chen, Mengyu Chen, Yongshuai Li, Jiarong Li, Qi Liu, Huan Xiong, Tangxi Guo, Yan Xie, Yufeng Yuan & Xiao-Lian Zhang. (2022) Abnormal ECA-Binding Membrane Glycans and Galactosylated CAT and P4HB in Lesion Tissues as Potential Biomarkers for Hepatocellular Carcinoma Diagnosis. Frontiers in Oncology 12.
Crossref
Crossref
Chakit Arora, Dilraj Kaur & Gajendra P. S. Raghava. (2021) Universal and cross‐cancer prognostic biomarkers for predicting survival risk of cancer patients from expression profile of apoptotic pathway genes. PROTEOMICS 22:3.
Crossref
Crossref
Danzan Mansorunov, Natalya Apanovich, Pavel Apanovich, Fatimat Kipkeeva, Tatyana Muzaffarova, Anna Kuzevanova, Maxim Nikulin, Olga Malikhova & Alexander Karpukhin. (2021) Expression of Immune Checkpoints in Malignant Tumors: Therapy Targets and Biomarkers for the Gastric Cancer Prognosis. Diagnostics 11:12, pages 2370.
Crossref
Crossref
Congyu Shi, Shan Liu, Xudong Tian, Xiaoyi Wang & Pan Gao. (2021) A TP53 mutation model for the prediction of prognosis and therapeutic responses in head and neck squamous cell carcinoma. BMC Cancer 21:1.
Crossref
Crossref
Jackwee Lim, Duygu Sari-Ak & Tanaya Bagga. (2021) Siglecs as Therapeutic Targets in Cancer. Biology 10:11, pages 1178.
Crossref
Crossref
Wen-Bo Yang, Cai-Peng Qin, Yi-Qing Du, Song-Chen Han & Tao Xu. (2021) Siglec-15 promotes progression of clear renal cell carcinoma. Chinese Medical Journal 134:21, pages 2635-2637.
Crossref
Crossref
Yun-Qian Cui, Yuan Xiang, Fei Meng, Chun-Hui Ji, Rui Xiao, Jia-Peng Li, Zhou-Tong Dai & Xing-Hua Liao. (2021) ALDH2 promotes uterine corpus endometrial carcinoma proliferation and construction of clinical survival prognostic model. Aging 13:20, pages 23588-23602.
Crossref
Crossref
Hang Du, Jingling Tang, Xiaoyun Li, Xinjun Wang, Liyun Wu, Ruyi Zhang, Pingsheng Hu & Yuan Yang. (2021) Siglec-15 Is an Immune Suppressor and Potential Target for Immunotherapy in the Pre-Metastatic Lymph Node of Colorectal Cancer. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Ziqi Huang, Baihui Li, Yan Guo, Lei Wu, Fan Kou & Lili Yang. (2021) Signatures of Multi-Omics Reveal Distinct Tumor Immune Microenvironment Contributing to Immunotherapy in Lung Adenocarcinoma. Frontiers in Immunology 12.
Crossref
Crossref
Qi Zhang, Manchao Kuang, Haiyin An, Yajing Zhang, Kai Zhang, Lin Feng, Lei Zhang & Shujun Cheng. (2021) Peripheral blood transcriptome heterogeneity and prognostic potential in lung cancer revealed by RNA‐Seq. Journal of Cellular and Molecular Medicine 25:17, pages 8271-8284.
Crossref
Crossref
Haiyan Zhang, Yongfei Xie, Zhi Hu, Hong Yu, Xiang Xie, Yingchun Ye, Wenfeng Xu, Siji Nian & Qing Yuan. (2021) Integrative Analysis of the Expression of SIGLEC Family Members in Lung Adenocarcinoma via Data Mining. Frontiers in Oncology 11.
Crossref
Crossref
Yang Song, Weiwei An, Hongmei Wang, Yuanren Gao, Jihua Han, Chenguang Hao, Lin Chen, Shilong Liu & Ying Xing. (2021) LRH1 Acts as an Oncogenic Driver in Human Osteosarcoma and Pan-Cancer. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Yifan Gao, Haoran Wang, Minhan Guo & Yajin Li. (2020) An adaptive machine learning pipeline for predicting the recurrence of gastric cancer. An adaptive machine learning pipeline for predicting the recurrence of gastric cancer.